Spironolactone Tablet, Film Coated
Product Images NDC 59746-217

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 59746-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmacuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg Bottle Label (100mg)

This text provides information about Spironolactone USP 100 mg tablets. It includes details on the usual dosage, storage instructions, manufacturing details, and the marketing company. The tablets are coated and come in a container with specific temperature storage requirements. The text also mentions keeping the medication out of reach of children.*

FDA Label Image

25mg Bottle Label (25mg)

FDA Label Image

50mg Bottle Label (50mg)

FDA Label Image

Structure (Structure)

FDA Label Image

Figure01 (Fig01)

The text mentions a statistical measure "Logerankp" with a significance level of less than 0.001, which indicates a strong statistical difference. It also refers to a comparison between Spironolactone and Placebo groups, with the number of participants in the Placebo group being 841 over a period of 2 months.*

FDA Label Image

Figure02 (Fig02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.